Trial site
Oxford University Hospitals NHS Foundation Trust
- 73running trials
- 23closed trials
The trials here
What the 96 trials at this site are about, from their registry records.
- Conditions
- Duchenne muscular dystrophy8 trials
- Follicular lymphoma5 trials
- Idiopathic pulmonary fibrosis5 trials
- Lung cancer5 trials
- High blood pressure4 trials
- Liver and biliary tract cancer4 trials
- Mantle cell lymphoma4 trials
- Pancreatic cancer4 trials
- Prostate cancer4 trials
- Stroke4 trials
- Ulcerative colitis4 trials
- Childhood cancers3 trials
- and 56 more
- Phase
- Phase 325 trials
- Phase 219 trials
- Phase 1/210 trials
- Phase 16 trials
- Phase 2/33 trials
- Phase 41 trial
- Status
- Active, not recruiting32 trials
- Recruiting32 trials
- Completed18 trials
- Not yet recruiting8 trials
- Terminated4 trials
- Enrolling by invitation1 trial
- Withdrawn1 trial
- Lead sponsor
- University of Oxford5 trials
- Janssen Research & Development, LLC4 trials
- Entrada Therapeutics, Inc.3 trials
- Hoffmann-La Roche3 trials
- Imperial College London3 trials
- and 65 more
Running trials
Recruiting
Not yet recruiting
Recruiting
A Study of CHM-029 in Participants With NPM1 Mutated, KMT2A or NUP98 Rearranged AML
Not yet recruiting
Recruiting
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Recruiting
Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma
Recruiting
Recruiting
Active, not recruiting
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis
Recruiting
Recruiting
Recruiting
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
Recruiting
Recruiting
Five Lives MED to Improve Cognitive Function in Mild Cognitive Impairment
Active, not recruiting
Recruiting
Recruiting
Supported Rescue Packs Post-discharge in Chronic Obstructive Pulmonary Disease
Recruiting
Recruiting
Active, not recruiting
Chronic Limb-Threatening Ischemia Treated With Intravascular Lithotripsy Observational Study
Recruiting
Robotic Inflammatory Bowel Disease Development, Learning and Efficacy Study
Active, not recruiting
A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis
Active, not recruiting
Recruiting
A Study of MGC026 in Participants With Advanced Solid Tumors
Recruiting
Active, not recruiting
Enrolling by invitation
Active, not recruiting
Recruiting
Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapy
Active, not recruiting
Recruiting
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
Active, not recruiting
Active, not recruiting
Closed-loop for People Living With Cystic Fibrosis Related Diabetes
Recruiting
DOLCE: Determining the Impact of Optellum's Lung Cancer Prediction Solution
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Recruiting
Awareness Detection and Communication in Disorders of Consciousness
Active, not recruiting
Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma
Recruiting
First-in-human Study of OVM-200 as a Therapeutic Cancer Vaccine
Active, not recruiting
Showing 50 of 73.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Duchenne muscular dystrophy5 recruiting
- Lung cancer5 recruiting
- Crohn's disease3 recruiting
- Follicular lymphoma3 recruiting
- High blood pressure3 recruiting
- Liver and biliary tract cancer3 recruiting
- Ovarian cancer3 recruiting
- Pancreatic cancer3 recruiting
- Prostate cancer3 recruiting
- Acute myeloid leukaemia2 recruiting
- Childhood cancers2 recruiting
- Chronic lymphocytic leukaemia2 recruiting
- Head and neck cancer2 recruiting
- Mantle cell lymphoma2 recruiting
- Melanoma2 recruiting
- Sarcoma2 recruiting
- Stroke2 recruiting
- Ulcerative colitis2 recruiting
- Atrial fibrillation1 recruiting
- Bladder cancer1 recruiting
- Cervical cancer1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Colorectal cancer1 recruiting
- COPD1 recruiting
- Coronary artery disease1 recruiting
- Deep vein thrombosis and pulmonary embolism1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Endometrial cancer1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Gestational diabetes1 recruiting
- Huntington's disease1 recruiting
- Hypertrophic cardiomyopathy1 recruiting
- Idiopathic pulmonary fibrosis1 recruiting
- Kidney cancer1 recruiting
- Liver cirrhosis1 recruiting
- Macular degeneration1 recruiting
- Multiple myeloma1 recruiting
- Myelodysplastic syndromes1 recruiting
- Neuroendocrine tumours1 recruiting
- Obesity1 recruiting
- Triple-negative breast cancer1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF
Recruiting
Completed
Completed
A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis
Completed
AI Assisted Reader Evaluation in Acute Computed Tomography (CT) Head Interpretation
Completed
Terminated
A Study of TCD601 (Siplizumab) in New Onset Type 1 Diabetes Patients
Completed
Efficacy and Safety on SOM3355 in Huntington's Disease Chorea
Completed
Completed
Recruiting
Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole
Completed
Completed
Immune Responses to COVID-19 Vaccination in Lymphoma Patients
Terminated
Completed
Terminated
Completed
The Efficacy and Mechanism of Trientine in Patients With Hypertrophic Cardiomyopathy
Completed
Completed
Completed
A Combination of Rituximab and Varlilumab Immunotherapy in Patients with B-cell Lymphoma
Completed
Terminated
A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026